Author： Christensson Camilla Thorén Anders Lindberg Bengt
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.31, Iss.11, 2008-01, pp. : 965-988
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral corticosteroid-related adverse events cost UK £84 million
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 585, 2009-01 ,pp. :
Access to resources
Recommend
Clinical Pharmacokinetics of Inhaled Budesonide
By Donnelly R.
Clinical Pharmacokinetics, Vol. 40, Iss. 6, 2001-01 ,pp. :
Systemic safety of inhaled corticosteroids
Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. :
Corticosteroid-related AEs come at high cost in SLE
Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. :
Inhaled Budesonide/Formoterol Combination
By McGavin J.K. Goa K.L. Jarvis B.
Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. :